Keytruda (pembrolizumab) is a prescription drug that’s used to treat certain forms of cancer. Keytruda comes as an intravenous (IV) infusion (an injection into your vein given over time).

Pembrolizumab and nivolumab [marketed as Keytruda and Opdivo] are currently being employed routinely in the relapsed and ...

It's the fourth gynaecological cancer approval for Keytruda meanwhile, which is also used to treat endometrial carcinoma without MSI-H or dMMR in combination with Eisai's multikinase inhibitor ...

MSD’s cancer immunotherapy, Keytruda, looks set to gain a lucrative first line lung cancer use in Europe, after regulators gave it the green light. Crucially, Keytruda (pembrolizumab ...

Merck (NYSE:MRK) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed its blockbuster anti-PD-1 therapy Keytruda in combination with ...

While some of the initial excitement around immunotherapies has waned, companies—particularly smaller biotechs—are developing ...

"These approvals underscore the continued expansion of the use of KEYTRUDA in diverse patient populations and treatment settings with utility of KEYTRUDA ranging from earlier lines of therapy to ...

Keytruda, which is approved in dozens of indications ... Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms ...

While further back, the acquisition of Schering Plough for $41 billion seems like a very strong use of capital as the deal brought in an early-stage Keytruda, but management has acknowledged that ...

Dow has been struggling to grow for several quarters. Keytruda now makes up close to half of Merck's revenue. As you can see ...

"These approvals underscore the continued expansion of the use of KEYTRUDA in diverse patient populations and treatment settings with utility of KEYTRUDA ranging from earlier lines of therapy to ...